<- Go Home

ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Market Cap

$492.4M

Volume

159.8K

Cash and Equivalents

$21.6M

EBITDA

-$17.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$18.4M

Profit Margin

60.38%

52 Week High

$19.00

52 Week Low

$5.11

Dividend

N/A

Price / Book Value

16.98

Price / Earnings

-25.86

Price / Tangible Book Value

17.35

Enterprise Value

$474.5M

Enterprise Value / EBITDA

-27.71

Operating Income

-$18.8M

Return on Equity

68.36%

Return on Assets

-28.04

Cash and Short Term Investments

$21.6M

Debt

$3.7M

Equity

$29.0M

Revenue

$30.4M

Unlevered FCF

-$1.4M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches